You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Prevention of skeletal-related events (pathological fracture, spinal cord compression, radiation to bone or surgery to bone) in patients with advanced malignancies involving bone., Treatment of tumour-induced hypercalcaemia (TIH)., As an adjunct to adjuvant treatment for women with early breast cancer who are in established menopause.
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Prevention of skeletal-related events (pathological fracture, spinal cord compression, radiation to bone or surgery to bone) in patients with advanced malignancies involving bone., Treatment of tumour-induced hypercalcaemia (TIH)., As an adjunct to adjuvant treatment for women with early breast cancer who are in established menopause.
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Prevention of skeletal-related events (pathological fracture, spinal cord compression, radiation to bone or surgery to bone) in patients with advanced malignancies involving bone., Treatment of tumour-induced hypercalcaemia (TIH)., As an adjunct to adjuvant treatment for women with early breast cancer who are in established menopause.
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Prevention of skeletal-related events (pathological fracture, spinal cord compression, radiation to bone or surgery to bone) in patients with advanced malignancies involving bone., Treatment of tumour-induced hypercalcaemia (TIH)., As an adjunct to adjuvant treatment for women with early breast cancer who are in established menopause.
Clear colourless sterile solution, practically free from visible particles in a clear plastic vial made of cycloolefine copolymer, 20mm bromobutyl rubber closure, alumunium flip off cap
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Prevention of skeletal-related events (pathological fracture, spinal cord compression, radiation to bone or surgery to bone) in patients with advanced malignancies involving bone., Treatment of tumour-induced hypercalcaemia (TIH)., As an adjunct to adjuvant treatment for women with early breast cancer who are in established menopause.
Clear colourless sterile solution, practically free from visible particles in a clear plastic vial made of cycloolefine copolymer, 20mm bromobutyl rubber closure, alumunium flip off cap
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Prevention of skeletal-related events (pathological fracture, spinal cord compression, radiation to bone or surgery to bone) in patients with advanced malignancies involving bone., Treatment of tumour-induced hypercalcaemia (TIH)., As an adjunct to adjuvant treatment for women with early breast cancer who are in established menopause.
Clear colourless sterile solution, practically free from visible particles in a clear plastic vial made of cycloolefine copolymer, 20mm bromobutyl rubber closure, alumunium flip off cap
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.
